Moringa and Breast Milk: What the Trials Found
Moringa leaf has a long reputation as a milk food. It is used to support breast-milk supply in the Philippines, where the tree is called malunggay, and the same custom is reported from Indonesia and elsewhere in Asia. The Moringa Benefits page sums up the milk-supply evidence in a few lines: traditional use with weak supporting trials. This page goes one level deeper. It takes the human studies that can be read in PubMed one at a time — who was studied, how much moringa was given, for how long, and what was actually measured — and then sets out what the systematic reviews make of them.
Two recent trials frame the question. A 3-month trial in Kenya found that mothers given moringa expressed more milk than mothers who were not. A double-blind trial in Thailand found no significant difference in milk volume on the third day after birth. Both are described in full below, along with the reviews, the safety record, and the long list of things nobody has yet measured.
Table of Contents
- Moringa Leaf Has a Long Tradition as a Milk Food
- The Kenyan Trial Ran for Three Months
- The Thai Trial Found No Significant Difference
- An Indonesian Soup Study Used a Weaker Design
- Reviews Rate the Evidence as Low or Very Low Certainty
- Moringa Has Rarely Been Tested Against Another Galactagogue
- What the Studies Measured and What They Left Out
- Safety Findings for Mother and Baby
- What Is Still Not Known
- Key Research Papers
- Connections
- Featured Videos
Moringa Leaf Has a Long Tradition as a Milk Food
A galactagogue is any food, herb or drug taken to increase breast-milk supply. LactMed, the U.S. National Institute of Child Health and Human Development's database on medicines and breastfeeding, records that moringa leaf "has been used as a galactogogue in Asia, particularly in the Philippines where it is called malunggay," and that the leaves "are widely used as a food and medicine in Asia and Africa."
Researchers in other countries describe the same custom. An Indonesian research team writes that moringa "has traditionally been used to increase breast milk production." A team studying the plant in rats notes that in various cultures it is used by pregnant women to increase milk production. A 2025 systematic review attributes the traditional use to the leaf's micronutrient and phytosterol content — that is the reviewers' explanation of the tradition, not a tested mechanism.
The traditional milk food is the leaf; the Indonesian study below served it as a vegetable soup. That matters for safety: the leaf and the root are chemically very different parts of the plant, as the safety section below explains. The story of how the Filipino custom first reached clinical trials, including the earliest Philippine studies, is told on the Moringa History page.
The Kenyan Trial Ran for Three Months
The longest trial described on this page was carried out in Kisumu County, Kenya, and published in 2025. Its design was published as a protocol in 2022.
- Design: a pilot, single-blinded, cluster-randomised trial. "Cluster-randomised by location" means whole communities, not individual mothers, were assigned to one group or the other.
- Who: 50 breastfeeding mother-infant pairs. The protocol enrolled mothers who were exclusively breastfeeding.
- What was given: 20 g a day of dried moringa leaf powder in corn porridge, divided twice daily according to the protocol. The control group received corn porridge alone.
- How long: 3 months.
- Pre-set main outcomes: the protocol named infant growth and maternal milk output as the primary outcomes.
- Completion: 45 of the 50 pairs (90%) completed the study.
What it found
- Milk output: after 3 months, mothers in the moringa group expressed a mean of 947 mL over 24 hours (95% confidence interval 794 to 1113 mL), against 618 mL in the control group (95% confidence interval 486 to 763 mL; P = 0.003). The authors describe this as "twice as much milk as controls."
- Infant growth: no effect. Babies in the moringa group did not grow differently from babies in the control group.
- Milk composition: no effect on total milk fat (lipid) or protein concentrations, or on fatty acids.
- Infant hormone level: infant serum insulin-like growth factor 1 (IGF-1), a growth-related hormone, was higher in the moringa group — a mean of 25.2 ng/mL against 17.8 ng/mL (P = 0.017).
The authors' own conclusion is careful: in this population, three months of maternal moringa "was associated with increased expressed milk output and higher circulating infant IGF-1 without impacting infant growth," and "additional studies are needed to understand the mechanisms driving these effects and their influence on long-term health."
The vitamin A results from the same trial
A companion paper from the same Kenyan trial looked at vitamin A, which an exclusively breastfed baby receives only through milk. The authors describe moringa leaf as a good food source of provitamin A and other carotenoids. Milk and blood samples were completed by 44 pairs (88%). Four mothers (9%) had vitamin A deficiency and 11 (25%) were vitamin A insufficient. Alpha-carotene in milk was higher in the moringa group — but it was already higher at the start (p = 0.024) as well as at the end (p = 0.014). The authors conclude that maternal moringa "did not impact concentration of milk vitamin A and resulted in limited increase in milk carotenoids in this cohort."
Reading the Kenyan trial carefully
- A pilot. The authors call it a pilot trial. With 50 pairs split between locations, it is small.
- Single-blinded. Mothers in one group ate porridge with moringa powder and mothers in the other ate plain porridge, so the food itself differed between the two arms.
- A food-scale amount. 20 g of leaf powder a day is far more than the 900 mg of capsules a day used in the Thai trial below. It is a nutritional dose given to mothers in a setting where vitamin A deficiency was present in some participants. The trial does not show whether the same effect would appear with capsule amounts, or in well-nourished mothers.
The Thai Trial Found No Significant Difference
A double-blind trial from Bangkok, Thailand, published in 2022, tested moringa leaf capsules in the first days after birth.
- Design: randomised, double-blind, placebo-controlled. Neither the mothers nor the researchers knew who received moringa.
- Who: 88 postpartum women.
- What was given: oral moringa leaf capsules, 900 mg a day, or oral placebo capsules.
- Main outcome: breast-milk volume on the third day after birth.
What it found
- Milk volume: no significant difference. The median volume on day 3 was 73.5 mL in the moringa group and 50 mL in the placebo group (p = 0.19).
- The authors add that "the amount of breast milk in the Moringa oleifera group was 47% more than the one in the control group" — but that difference was not statistically significant, so chance cannot be ruled out.
- Later breastfeeding: the exclusive breastfeeding rate at 6 months was 52.3% in the moringa group, which the authors note met World Health Organization goals.
The paper's own conclusion holds both results side by side: "even 900 mg/day of the Moringa oleifera leaf could not significantly increase breast milk volume in early postpartum mothers," yet the authors still write that moringa leaf "may be used as a galactagogue herb." Readers can see both statements in the abstract. As a test of its main question, the trial is a null result.
The Thai and Kenyan trials differ in almost every way — 900 mg of capsules against 20 g of food powder, a day-3 measurement against a 3-month trial, day-3 volume against 24-hour expressed volume, double-blind against single-blind. They do not contradict each other so much as answer different questions.
An Indonesian Soup Study Used a Weaker Design
A 2024 study from rural Batang-Batang District, Indonesia, tested moringa as food rather than as a supplement.
- Design: quasi-experimental — the groups were not formed by random allocation, and there was no placebo.
- Who: 40 breastfeeding mothers of stunted toddlers aged 0 to 2 years; 20 received moringa leaf vegetable soup and 20 received no treatment.
- Amount: the abstract does not state how much moringa the soup contained or for how long it was eaten.
- Outcome: whether milk production was "adequate," a yes-or-no category rather than a measured volume.
In the soup group, 57% of mothers had adequate milk production before the study and 76% afterwards. The authors report a significant difference on a Mann-Whitney U test (printed as p = 0.000). Without randomisation, blinding or a measured milk volume, the study shows an association in a small group rather than a tested effect.
Reviews Rate the Evidence as Low or Very Low Certainty
Several groups have tried to add up the moringa milk studies. They differ in what they include, and so in how confident they sound, but none rates the evidence as high certainty.
The 2025 moringa-only systematic review
A 2025 review in Foods searched for randomised controlled trials of moringa leaf in postpartum women. Eight studies met its criteria, and the interventions lasted from 3 to 10 days. The reviewers report that moringa "increased significantly breast milk volume by up to 400 mL/day compared to controls," and that serum prolactin — the main milk-making hormone — rose "with a mean increase of 231.72 ng/mL." Most studies had low to moderate risk of bias; one had a high risk because it lacked blinding and used a subjective outcome. The reviewers call for "further longer-term studies" to establish optimal dosing, sustained effectiveness and safety.
The 2020 Cochrane review of all galactagogues
The Cochrane review covered 41 randomised trials involving 3005 mothers and 3006 infants, testing both drugs and natural galactagogues in mothers of healthy term babies. Moringa was among the natural products studied. Its findings for moringa are limited by the way the studies differed from one another:
- Infant weight: three studies (testing fennel, fenugreek, moringa and a mixed botanical tea; 275 participants) reported infant weight but could not be combined because they differed too much. The subgroup analysis suggested that moringa and the mixed tea "may increase infant weight compared to placebo," at very low certainty.
- Milk volume: thirteen studies, moringa among them (962 participants), reported milk volume, but meta-analysis was not possible because of substantial heterogeneity (I² = 99%). Individual subgroups suggested "either benefit or little or no difference," at very low certainty.
- Overall: the authors concluded that natural galactagogues may benefit infant weight and milk volume, but "we are very uncertain about the magnitude of the effect," and that "high-quality RCTs on the efficacy and safety of galactagogues are urgently needed."
The 2026 review in mothers of premature babies
A 2026 review in the European Journal of Clinical Nutrition looked only at randomised trials of herbal galactagogues in mothers who delivered prematurely, a group whose babies' risk of necrotising enterocolitis and sepsis is reduced by breast milk, and in which breastfeeding rates are lower than in term babies. Ten trials were included, each testing a different herb or mixture; two were at high risk of bias and the rest had "some concerns." The authors list moringa leaf capsules among five preparations with "low certainty evidence" of increased breast-milk production. The abstract gives mean differences in milk volume for four of the other preparations, but not for moringa.
Other reviews
- A 2022 systematic review of moringa in humans and animals found 33 studies (7 human, 26 animal). In humans, moringa at 0.5 g a day "also increased breastmilk volumes." In animals, moringa increased milk production in two of three studies. The authors judged the evidence "limited but promising."
- A 2016 review of herbal and drug galactagogues found blinded, placebo-controlled trials for five popular herbs, malunggay among them. Results for the herbs "were mixed," and the authors describe "a dearth of high-quality clinical trials."
- LactMed's moringa entry cites a meta-analysis of 14 studies and 865 subjects that "indicates that Moringa increases serum prolactin and milk volume and quality," and adds that "the long-term benefit to breastfed infants has not been well studied."
Put together, the reviews agree on direction more than on confidence: most report more milk with moringa, but the trials are small and short, and the formal certainty ratings run from low to very low.
Moringa Has Rarely Been Tested Against Another Galactagogue
Most moringa studies compare it with a placebo or with nothing. The Cochrane review found eight studies that compared one galactagogue directly with another — moringa and domperidone among the products tested — but "there was only one small study for each match-up, so we do not know if one galactagogue is better than another for any outcome."
The drug side of the comparison has its own uncertainties. Domperidone and metoclopramide are prescription drugs that are sometimes prescribed to increase milk supply. In the Cochrane review, three trials of drugs (metoclopramide, domperidone and sulpiride; 151 participants) suggested they "may increase milk volume," by a mean difference of 63.82 mL, at low certainty. A 2024 network meta-analysis of 17 randomised trials found that domperidone increased daily milk volume in mothers of preterm infants compared with placebo (mean difference 88.30 mL a day), but not significantly in mothers of term infants, and that metoclopramide "was no better than the placebo" in either group.
These drug figures come from different trials, different mothers and different ways of measuring milk, so they cannot be lined up against the moringa figures as a head-to-head result. What can be said is that neither the drugs nor moringa have been compared with each other in a trial large enough to settle which, if either, works better.
The sister pages on Shatavari, Fennel, Fenugreek and Blessed Thistle examine the other well-known herbal galactagogues in the same way.
What the Studies Measured and What They Left Out
"Moringa increases milk" can mean very different things depending on what was counted. Across the studies on this page, the outcomes were:
- Milk volume, measured in different ways. The Kenyan trial measured 24-hour expressed milk after 3 months. The Thai trial measured volume on day 3 after birth. The Indonesian study recorded whether supply was "adequate," without a volume. These are not interchangeable, which is one reason the reviews could not always pool results.
- Infant growth or weight. The Kenyan trial found no effect on infant growth. The Cochrane review found a possible gain in infant weight with moringa, at very low certainty.
- Prolactin. The 2025 review reports a rise in mothers' serum prolactin. Prolactin is the pituitary hormone that signals the breast to make milk; the lactation and oxytocin animation shows the loop.
- Milk quality. In Kenya, no effect on milk fat, protein, fatty acids or milk vitamin A, and only a limited rise in milk carotenoids.
- Infant hormones. Higher infant insulin-like growth factor 1 in the Kenyan moringa group, with no difference in growth.
Outcomes that matter most to families were rarely measured. For galactagogues in general, the Cochrane review found that the share of mothers still breastfeeding at 3, 4 and 6 months was barely reported, and it called for "a set of core outcomes to standardise infant weight and milk volume measurement" and "a strong basis for the dose and dosage form used." The doses in the moringa studies span from 0.5 g a day of leaf to 20 g a day of powder, and from three days to three months, which makes it hard to say what amount any finding refers to.
Safety Findings for Mother and Baby
What the human studies reported
LactMed states that "studies have found no serious short-term adverse effects in nursing mothers who ingested Moringa leaves or in their breastfed infants." A 2023 narrative review of 12 studies of moringa in pregnancy and breastfeeding reports that "none of the studies analysed reported contraindications to the use of the supplement during pregnancy and lactation." A 2015 safety review of moringa found that "no adverse effects were reported in association with human studies," and noted that "standardization of products is an issue." Across all natural galactagogues, the Cochrane review found adverse effects poorly reported, and those that were reported were minor complaints.
Short-term absence of reported harm is not the same as long-term safety data. LactMed notes that long-term benefit to breastfed infants "has not been well studied," and the 2025 systematic review lists safety among the questions still needing longer-term studies.
What the animal studies reported
In rats, leaf and seed flour given at 100 mg per kg of body weight through pregnancy and lactation did not affect the mothers' weight gain, did not harm the birth of the pups, and did not cause abortions or mutations in the offspring. In another rat study, a blend of three plant extracts that included moringa raised milk production at one of the doses tested — but with three plants in the blend, it says nothing about moringa alone, and nothing about women.
The root is not the leaf
Every trial on this page used the leaf. As set out on the Moringa Benefits page, the root and root bark concentrate alkaloids, and root bark has a traditional use as an abortifacient and to bring on menstruation; high-dose leaf supplements and concentrated extracts have no adequate safety data in pregnancy. A product label that names the leaf states the plant part; one that says only "moringa" does not.
Interactions reported for moringa
- Blood clotting. LactMed notes that moringa "may stimulate blood clotting" and advises caution "in anyone at high risk for blood clots".
- Cytochrome P450 3A4. In a laboratory test with human liver enzymes, moringa leaf extracts inhibited cytochrome P450 3A4, the enzyme that clears many drugs; root extracts were less active. When this was tested in people, 11 adults with human immunodeficiency virus (HIV) taking the drug nevirapine were given 1.85 g of moringa leaf powder a day for 14 days. The ratio of nevirapine exposure (area under the blood-level curve) after versus before moringa was 1.07 (90% confidence interval 1.00 to 1.14), and the authors concluded that moringa at the traditional dose "did not significantly alter" nevirapine levels.
- Blood sugar, blood pressure and thyroid drugs. These reported interactions are covered on the Moringa Benefits page and its Blood Sugar and Cholesterol article.
LactMed notes that dietary supplements do not require extensive pre-marketing approval from the U.S. Food and Drug Administration, and that "differences are often found between labeled and actual ingredients or their amounts," and that "clinical testing results on one product may not be applicable to other products." LactMed also states that galactagogues "should never replace evaluation and counseling on modifiable factors that affect milk production." Decisions about any supplement while breastfeeding belong with a clinician or lactation consultant.
What Is Still Not Known
- Which result holds. The double-blind Thai capsule trial was null; the single-blind Kenyan food trial was positive. None of the studies described here was both double-blind and months long.
- The right amount and form. Studies used anything from 0.5 g of leaf to 20 g of powder a day, as capsules, porridge or soup. The 2025 systematic review lists optimal dosing as unresolved.
- Whether any effect lasts. The trials in the 2025 systematic review lasted 3 to 10 days. Whether moringa changes how long mothers breastfeed is not known.
- How it might work. A rise in prolactin is reported in pooled data, but the Kenyan authors state that further studies are needed "to understand the mechanisms driving these effects."
- What reaches the baby. Apart from the milk carotenoids measured in Kenya, whether moringa's plant compounds pass into breast milk, and in what amounts, is not reported in the studies on this page.
- Long-term infant outcomes. The higher infant insulin-like growth factor 1 seen in Kenya, with no change in growth, has not been followed up. LactMed states that the long-term benefit to breastfed infants has not been well studied.
- Head-to-head comparisons. Whether moringa performs better or worse than other herbs or drugs is not known, because each comparison rests on a single small study.
Key Research Papers
- Attia SL, Owuor PM, Odhiambo SA, Mogaka JN, Ondondo R, Navarro IC, Schadler A, McQuerry K, Fuchs GJ 3rd, Williams JE, Scarrow KN, McGuire MA, McGuire MK, Waterman C. Effect of Maternal Moringa oleifera Leaf Supplementation on Maternal and Infant Nutritional Status and Human Milk Output: A Pilot Single-Blinded Cluster-Randomized Trial. Current Developments in Nutrition. 2025;9(11):107568. PubMed PMID: 41282517
- Attia SL, Odhiambo SA, Mogaka JN, Ondondo R, Schadler A, McQuerry K, Fuchs GJ 3rd, Williams JE, McGuire MK, Waterman C, Schulze K, Owuor PM. Impact of Maternal Moringa oleifera Leaf Supplementation on Milk and Serum Vitamin A and Carotenoid Concentrations in a Cohort of Breastfeeding Kenyan Women and Their Infants. Nutrients. 2024;16(19):3425. PubMed PMID: 39408390
- Mogaka JN, Owuor PM, Odhiambo S, Waterman C, McGuire MK, Fuchs GJ, Attia SL. Investigating the Impact of Moringa oleifera Supplemented to Kenyan Breastfeeding Mothers on Maternal and Infant Health: A Cluster Randomized Single-Blinded Controlled Pilot Trial Protocol. JPGN Reports. 2022;3(3):e237. PubMed PMID: 37168619
- Fungtammasan S, Phupong V. The effect of Moringa oleifera capsule in increasing breast milk volume in early postpartum patients: A double-blind, randomized controlled trial. European Journal of Obstetrics & Gynecology and Reproductive Biology: X. 2022;16:100171. PubMed PMID: 36440058
- Yasin Z, Nawawi A, Wibowo A, Nadhiroh SR, Devy SR. Effects of Moringa oleifera on increasing breast milk in breastfeeding mothers with stunting toddlers in rural Batang-Batang District, Indonesia. African Journal of Reproductive Health. 2024;28(10s):34-4. PubMed PMID: 39635867
- Ammar M, Russo GL, Altamimi A, Altamimi M, Sabbah M, Al-Asmar A, Di Monaco R. Moringa oleifera Supplementation as a Natural Galactagogue: A Systematic Review on Its Role in Supporting Milk Volume and Prolactin Levels. Foods. 2025;14(14):2487. PubMed PMID: 40724308
- Foong SC, Tan ML, Foong WC, Marasco LA, Ho JJ, Ong JH. Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants. Cochrane Database of Systematic Reviews. 2020;5(5):CD011505. PubMed PMID: 32421208
- Cragg A, Levene I, Darabi S, Willcox M. Herbal galactagogues to improve breastmilk production and lactation in mothers of preterm babies: a systematic review of clinical trials. European Journal of Clinical Nutrition. 2026;80(2):146-158. PubMed PMID: 41350450
- Brar S, Haugh C, Robertson N, Owuor PM, Waterman C, Fuchs GJ 3rd, Attia SL. The impact of Moringa oleifera leaf supplementation on human and animal nutrition, growth, and milk production: A systematic review. Phytotherapy Research. 2022;36(4):1600-1615. PubMed PMID: 35302264
- Bazzano AN, Hofer R, Thibeau S, Gillispie V, Jacobs M, Theall KP. A Review of Herbal and Pharmaceutical Galactagogues for Breast-Feeding. Ochsner Journal. 2016;16(4):511-524. PubMed PMID: 27999511
- Moringa. Drugs and Lactation Database (LactMed). National Institute of Child Health and Human Development. 2006. PubMed PMID: 30000959
- Si S, Zhao G, Song G, Liu J. Efficacy and safety of domperidone and metoclopramide on human milk production in postpartum mothers: a bayesian network meta-analysis of randomized controlled trials. BMC Pregnancy and Childbirth. 2024;24(1):819. PubMed PMID: 39695450
- Rotella R, Soriano JM, Llopis-González A, Morales-Suarez-Varela M. The Impact of Moringa oleifera Supplementation on Anemia and other Variables during Pregnancy and Breastfeeding: A Narrative Review. Nutrients. 2023;15(12):2674. PubMed PMID: 37375577
- Stohs SJ, Hartman MJ. Review of the Safety and Efficacy of Moringa oleifera. Phytotherapy Research. 2015;29(6):796-804. PubMed PMID: 25808883
- Dantas DL, Alves MDC, Dantas GMS, Campos ARN, Santana RAC, Soares JKB, Freitas JCR. Supplementation with Moringa oleifera Lam leaf and seed flour during the pregnancy and lactation period of Wistar rats: Maternal evaluation of initial and adult neurobehavioral development of the rat progeny. Journal of Ethnopharmacology. 2024;325:117904. PubMed PMID: 38342151
- Intan PR, Alegantina S, Isnawati A, Yunarto N, Ekawasti F, Rinendyaputri R, Sunarno S, Sani Y, Mariya SS, Handharyani E. Effects of a blend extract of Sauropus androgynus, Moringa oleifera, and Coleus amboinicus on milk production in lactating rats. Open Veterinary Journal. 2024;14(12):3630-3639. PubMed PMID: 39927372
- Monera TG, Wolfe AR, Maponga CC, Benet LZ, Guglielmo J. Moringa oleifera leaf extracts inhibit 6beta-hydroxylation of testosterone by CYP3A4. Journal of Infection in Developing Countries. 2008;2(5):379-83. PubMed PMID: 19745507
- Monera-Penduka TG, Maponga CC, Wolfe AR, Wiesner L, Morse GD, Nhachi CF. Effect of Moringa oleifera Lam. leaf powder on the pharmacokinetics of nevirapine in HIV-infected adults: a one sequence cross-over study. AIDS Research and Therapy. 2017;14:12. PubMed PMID: 28293270
PubMed Topic Searches
Connections
- Moringa Benefits — the evidence hub for this article
- Moringa — the main topic page for the plant
- Moringa: History and Traditional Use — how the malunggay custom reached the first trials
- Nutrition and the Superfood Claims — what a spoon of leaf powder really contains
- Water Purification and Food Security — the leaf in undernutrition
- Blood Sugar and Cholesterol — including the nevirapine interaction study
- Shatavari: Breast Milk and Lactation Claims — the Ayurvedic milk herb, examined the same way
- Fennel: Lactation and Galactagogue — a kitchen spice with the same reputation
- Fenugreek for Lactation — the best-known herbal galactagogue
- Blessed Thistle and Breastfeeding — another milk herb, examined
- How Breast Milk Is Made — an animation of prolactin and the let-down reflex
- Vitamin A — the nutrient the Kenyan trial tracked in milk